[6-K] ELTEK LTD Current Report (Foreign Issuer)
Rhea-AI Filing Summary
Eltek Ltd. reported a weak first quarter of 2026, as revenue fell to $10.4 million from $12.8 million a year earlier and the company moved from a gross profit to a gross loss of $1.9 million. The quarter swung to a net loss of $2.9 million, or $0.42 per diluted share, compared with net income of $1.0 million in the prior-year period.
Management attributed the deterioration mainly to sharp depreciation of the U.S. dollar against the Israeli shekel, which increased shekel-based operating expenses by about $1.3 million, as well as regional security-related disruptions and late phasing of the order backlog. EBITDA turned to a loss of $2.7 million from positive EBITDA of $1.2 million. Despite the weaker results, Eltek ended March 31, 2026 with $11.1 million in cash and short-term deposits and no outstanding debt.
Positive
- None.
Negative
- None.
Insights
Eltek’s Q1 2026 shows a sharp swing to losses driven by currency and operational headwinds.
Eltek Ltd. saw revenue decline to $10.4 million while gross margin flipped from profit to a $1.9 million loss. Operating income dropped from a $725 thousand profit to a $3.3 million loss, reflecting both lower volumes and higher reported costs.
Management cites about $1.3 million of additional shekel-based operating expenses from U.S. dollar depreciation, along with logistical issues and regional security-related disruptions. These factors also drove EBITDA from a $1.2 million gain to a $2.7 million loss, underscoring how sensitive results are to currency and operating stability.
Despite the earnings setback, the balance sheet shows $11.1 million of cash and short-term deposits and no debt as of March 31, 2026. Management highlights significant growth in the order backlog and expresses confidence in converting it to revenue over coming periods, though actual recovery will depend on execution and macro conditions.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2026
Commission file number 000-28884
Eltek Ltd.
(Name of Registrant)
Sgoola Industrial Zone, Petach Tikva, Israel
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Eltek Ltd.
EXPLANATORY NOTE
On May 19, 2026 Eltek issued a press release reporting first quarter 2026 financial results. A copy of this press release is furnished herewith as Exhibit 99.1.
EXHIBIT INDEX
| Exhibit | Description | |
| 99.1 | Press Release: Eltek Ltd. Reports 2026 First Quarter Financial Results |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ELTEK LTD. | |
| (Registrant) | |
| By: /s/Ron Freund | |
| Ron Freund | |
| Chief Financial Officer |
Date: May 19, 2026
Exhibit 99.1
Press Release
Eltek Ltd. Reports 2026 First Quarter Financial Results
Petach Tikva, Israel (May 19, 2026) Eltek Ltd. (NASDAQ: ELTK), a leading global manufacturer of high-quality printed circuit boards, today announced its financial results for the quarter ended March 31, 2026.
First Quarter 2026 Highlights
| § | Revenues of $10.4 million |
| § | Operating loss of $1.9 million |
| § | Net loss of $2.9 million or $0.42 per fully diluted share |
| § | Net cash used in operating activities amounted to $0.4 million. |
The continuous sharp depreciation of the U.S. dollar against the Israeli shekel had a material impact on the Company’s operating results. This currency movement increased the Company’s shekel-denominated expenses when translated into U.S. dollars, resulting in an increase of approximately $1.3 million in reported NIS-based operating expenses, compared to the first quarter of 2025. In addition, the Company’s operations during the quarter were affected by the challenging security environment in the region, including temporary disruptions to regular work routines and reduced operational availability at certain times.
“As we indicated in April 2026, our operating results for the quarter were adversely affected by the late phasing of the Company’s order backlog during the quarter, although our backlog has grown significantly. In addition, we experienced certain temporary logistical constraints, which contributed to the results for the quarter,” said Eli Yaffe, CEO of Eltek.
“The continued growth in our order backlog reflects the underlying strength in demand for our products. While the timing of backlog execution impacted our results in the first quarter, we remain confident in our ability to convert this backlog into revenue over the coming periods. At the same time, we are actively addressing the logistical challenges and expect conditions to improve gradually,” concluded Mr. Yaffe.
First Quarter 2026 GAAP Financial Results
Revenues for the first quarter of 2026 were $10.4 million, compared to $12.8 million in the first quarter of 2025.
Gross loss for the first quarter of 2026 was $1.9 million compared to gross profit of $2.2 (17% of revenues) in the first quarter of 2025.
Operating loss for the first quarter of 2026 was $3.3 million compared to operating profit of $0.7 million in the first quarter of 2025.
Net loss for the first quarter of 2026 was $2.9 million or $0.42 per fully diluted share compared to net income of $1.0 million or $0.15 per fully diluted share in the first quarter of 2025.
Cash and short-term bank deposits amounted to $11.1 million as of March 31, 2026, with no outstanding debt.
First Quarter 2026 Non-GAAP Financial Results
EBITDA loss for the first quarter of 2026 was $2.7 million compared to EBITDA of $1.2 million (9% of revenues) in the first quarter of 2025.
About our Non-GAAP Financial Information
The Company reports financial results in accordance with U.S. GAAP and herein provides EBITDA, a non-GAAP measure. This non-GAAP measure is not in accordance with, nor is it a substitute for, GAAP measures. This non-GAAP measure is intended to supplement the Company’s presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measure presented to evaluate and manage the Company’s operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the Company's results on a GAAP and non-GAAP basis is provided in a table below.
Conference Call
Today, Tuesday, May 19, 2026, at 8:30am Eastern Time (15:30pm Israel Time, 5:30am Pacific Time), Eltek will conduct a conference call to discuss the results. The call will feature remarks by Eli Yaffe, Chief Executive Officer and Ron Freund, Chief Financial Officer.
To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:
| United States: | 1-866-860-9642 |
| Israel: | 03-918-0691 |
| International: | +972-3-918-0691 |
To Access a Replay of the Call
A replay of the call will be available for 30 days on the Investor Info section on Eltek’s corporate website at http://www.nisteceltek.com approximately 24 hours after the conference call is completed.
About Eltek
Eltek – ”Innovation Across the Board”, is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs) and is an Israeli leading company in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high-quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek is ITAR compliant and has AS-9100 and NADCAP Electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.
Eltek was founded in 1970. The Company’s headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiary in North America and by agents and distributors in Europe, India, South Africa and South America.
For more information, visit Eltek's web site at www.nisteceltek.com
Forward Looking Statements
Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future quarters, the impact of currency movements between the US Dollar exchange rate against the Israeli Shekel, the impact of the Coronavirus on the economy and our operations, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company’s Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.
Investor Contact
Ron Freund
Chief Financial Officer
Investor-Contact@nisteceltek.com
+972-3-939-5023
(Tables follow)
| Eltek Ltd. |
| Consolidated Statements of Income |
| U.S. dollars in thousands (except per share data) |
| Three months ended | ||||||||
| March 31, | ||||||||
| 2026 | 2025 | |||||||
| Revenues | 10,436 | 12,756 | ||||||
| Costs of revenues | (12,288 | ) | (10,544 | ) | ||||
| Gross profit (loss) | (1,852 | ) | 2,212 | |||||
| Research and development, expenses, net | - | (50 | ) | |||||
| Selling, general and administrative expenses | (1,415 | ) | (1,437 | ) | ||||
| Operating income (loss) | (3,267 | ) | 725 | |||||
| Financial income (expenses), net | (94 | ) | 504 | |||||
| Income (loss) before income taxes | (3,361 | ) | 1,229 | |||||
| Income tax expenses (tax benefit) | (508 | ) | 227 | |||||
| Net Income (loss) | (2,853 | ) | 1,002 | |||||
| Earnings per share: | ||||||||
| Basic net income (loss) per ordinary share | (0.42 | ) | 0.15 | |||||
| Diluted net income (loss) per ordinary share | (0.42 | ) | 0.15 | |||||
| Weighted average number of ordinary shares used to compute | ||||||||
| basic net income (loss) per ordinary share (in thousands) | 6,719 | 6,714 | ||||||
| Weighted average number of ordinary shares used to compute | ||||||||
| diluted net income (loss) per ordinary share (in thousands) | 6,786 | 6,785 | ||||||
| Eltek Ltd. |
| Consolidated Balance Sheets |
| U.S. dollars in thousands |
| March 31, | December 31, | |||||||
| 2026 | 2025 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | 11,054 | 2,481 | ||||||
| Short-term bank deposits | - | 9,643 | ||||||
| Trade receivables (net of allowance for credit losses) | 11,338 | 14,789 | ||||||
| Inventories | 9,373 | 11,154 | ||||||
| Other accounts receivable and prepaid expenses | 699 | 607 | ||||||
| Total current assets | 32,464 | 38,674 | ||||||
| Long term assets: | ||||||||
| Severance pay fund | 71 | 65 | ||||||
| Deferred tax assets, net | 913 | 387 | ||||||
| Operating lease right-of-use assets | 11,851 | 6,272 | ||||||
| Total long term assets | 12,835 | 6,724 | ||||||
| Property and equipment, net | 22,647 | 20,862 | ||||||
| Total Assets | 67,946 | 66,260 | ||||||
| Liabilities and Shareholder's equity | ||||||||
| Current liabilities: | ||||||||
| Trade payables | 5,032 | 6,047 | ||||||
| Other accounts payable and accrued expenses | 5,913 | 6,565 | ||||||
| Short-term operating lease liabilities | 494 | 1,100 | ||||||
| Total current liabilities | 11,439 | 13,712 | ||||||
| Long-term liabilities: | ||||||||
| Accrued severance pay | 528 | 515 | ||||||
| Long-term operating lease liabilities | 11,629 | 5,296 | ||||||
| Total long-term liabilities | 12,157 | 5,811 | ||||||
| Shareholders' equity: | ||||||||
| Ordinary shares, NIS 3.0 par value authorized 10,000,000 shares, issued and outstanding 6,719,827 at March 31, 2026 and December 31, 2025 | 6,012 | 6,012 | ||||||
| Additional paid-in capital | 32,662 | 32,662 | ||||||
| Foreign currency translation adjustments | 6,462 | 6,111 | ||||||
| Capital reserve | 3,134 | 3,019 | ||||||
| Retained earnings (accumulated deficit) | (3,920 | ) | (1,067 | ) | ||||
| Total shareholders' equity | 44,350 | 46,737 | ||||||
| Total liabilities and shareholders' equity | 67,946 | 66,260 | ||||||
| Eltek Ltd. |
| Unaudited Non-GAAP EBITDA Reconciliations |
| U.S. dollars in thousands |
| Three months ended | ||||||||
| March 31, | ||||||||
| 2026 | 2025 | |||||||
| GAAP net Income (loss) | (2,853 | ) | 1,002 | |||||
| Add back items: | ||||||||
| Financial (income) expenses, net | 94 | (504 | ) | |||||
| Income tax expenses (tax benefit) | (508 | ) | 227 | |||||
| Depreciation and amortization | 590 | 465 | ||||||
| Non-GAAP EBITDA (EBITDA loss) | (2,677 | ) | 1,190 | |||||
| Eltek Ltd. |
| Consolidated Statements of Cash Flows |
| U.S. dollars in thousands |
| Three months ended | ||||||||
| March 31, | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net Income (loss) | (2,853 | ) | 1,002 | |||||
| Adjustments to reconcile net income to net cash flows | ||||||||
| provided by operating activities: | ||||||||
| Depreciation | 590 | 465 | ||||||
| Accrued interest, net | (69 | ) | (128 | ) | ||||
| Share-based compensation | 115 | 138 | ||||||
| Decrease (increase) in deferred tax assets | (530 | ) | 82 | |||||
| 106 | 557 | |||||||
| Decrease (increase) in operating lease right-of-use assets | 149 | 1 | ||||||
| Decrease (increase) in trade receivables | 3,618 | (355 | ) | |||||
| Decrease (increase) in other receivables and prepaid expenses | (88 | ) | (67 | ) | ||||
| Decrease (increase) in inventories | 1,895 | (330 | ) | |||||
| Increase (decrease) in trade payables | (2,507 | ) | (862 | ) | ||||
| Increase (decrease) in other liabilities and accrued expenses | (714 | ) | 173 | |||||
| Increase (decrease) in employee severance benefits, net | 9 | 7 | ||||||
| 2,362 | (1,433 | ) | ||||||
| Net cash provided by (used in) operating activities | (385 | ) | 126 | |||||
| Cash flows from investing activities: | ||||||||
| Purchase of fixed assets | (739 | ) | (1,137 | ) | ||||
| Withdrawal of (investment in) short-term bank deposits, net | 9,712 | 534 | ||||||
| Net cash provided by (used in) investing activities | 8,973 | (603 | ) | |||||
| Cash flows from financing activities: | ||||||||
| Exercise of options | - | - | ||||||
| Repayment of long-term loans from bank | - | - | ||||||
| Issuance of shares, net | - | - | ||||||
| Net cash provided by (used in) financing activities | - | - | ||||||
| Effect of translation adjustments | (15 | ) | (632 | ) | ||||
| Net increase (decrease) in cash and cash equivalents | 8,573 | (1,109 | ) | |||||
| Cash and cash equivalents at the beginning of the period | 2,481 | 7,575 | ||||||
| Cash and cash equivalents at the end of the period | 11,054 | 6,466 | ||||||